Homology Medicines: 3Q Earnings Snapshot

November 13, 2018

BEDFORD, Mass. (AP) _ Homology Medicines Inc. (FIXX) on Tuesday reported a loss of $14.8 million in its third quarter.

The Bedford, Massachusetts-based company said it had a loss of 40 cents per share.

The gene editing company posted revenue of $954,100 in the period. Its adjusted revenue was $954,000.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FIXX at https://www.zacks.com/ap/FIXX

All contents © copyright 2019 The Associated Press.All rights reserved.